ICT产品代理
ICT产品代理
我们的使命是开发创新的细胞疗法来改变全球癌症治疗
Innovation Cellular Therapeutics (ICT) 是一家私人临床阶段生物技术公司，总部位于马里兰州罗克维尔。 ICT 专注于开发用于治疗实体瘤的细胞免疫疗法。 ICT 独特的 CoupledCAR® 技术平台旨在克服治疗实体瘤的常见挑战。 ICT 在晚期实体瘤（如结直肠癌和甲状腺癌）中取得了有希望的临床前和概念验证临床结果。 公司拥有广泛的 CAR-T 候选产品线，针对其他实体瘤。
公司里程碑
ICT已发展成为具有世界一流能力的完全整合的国际CAR-T生物技术公司。
Innovative Cellular Therapeutics
Our mission is to develop innovative cellular therapies to transform cancer treatment worldwide
Innovative Cellular Therapeutics (ICT) is a private clinical stage biotechnology company headquartered in Rockville, MD. ICT is focused on the development of cellular immunotherapies for the treatment of solid tumors. ICT’s unique CoupledCAR®
technology platform is designed to overcome the common challenges of treating solid tumors. ICT has achieved promising preclinical and proof-of-concept clinical results in late-stage solid tumors, such as colorectal cancer and thyroid cancer. The Company has a broad pipeline of CAR-T candidates targeting additional solid tumors.
Corporate Milestones
ICT has evolved into a fully integrated, international CAR-T biotechnology company with world-class capabilities.
